Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders.

Literature DB >> 5364729

Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders.

M Saunders, M Knowles, S Currie.

Abstract

Entities: Disease

Mesh：

Substances：
Antibodies
Glycogen

Year: 1969 PMID： 5364729 PMCID： PMC496591 DOI： 10.1136/jnnp.32.6.569

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

× No keyword cloud information.

17 in total

1. Treatment of dermatomyositis with methotrexate.

Authors: A N Malaviya; A Many; R S Schwartz
Journal: Lancet Date: 1968-08-31 Impact factor: 79.321

2. Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases.

Authors: D Hughes; E A Caspary; E J Field
Journal: Lancet Date: 1968-12-07 Impact factor: 79.321

3. Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients.

Authors: R K Winkelmann; D W Mulder; E H Lambert; F M Howard; G R Diessner
Journal: Mayo Clin Proc Date: 1968-08 Impact factor: 7.616

4. Polymyositis: a clinical study.

Authors: R G Logan; J M Bandera; W M Mikkelsen; I F Duff
Journal: Ann Intern Med Date: 1966-11 Impact factor: 25.391

5. Experimental myositis associated with hypersensitivity to muscle.

Authors: R L Dawkins
Journal: J Pathol Bacteriol Date: 1965-10

6. Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors: E M Hersh; J J Oppenheim
Journal: N Engl J Med Date: 1965-11-04 Impact factor: 91.245

7. Response of human blood lymphocytes to tuberculin PPD in tissue culture.

Authors: A S Coulson; D G Chalmers
Journal: Immunology Date: 1967-04 Impact factor: 7.397

8. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.

Authors: J Houseley; J J Oppenheim
Journal: Br Med J Date: 1967-06-10

9. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis.

Authors: A L Rose; J N Walton
Journal: Brain Date: 1966-12 Impact factor: 13.501

10. In vitro destruction of skeletal muscle by sensitized cells.

Authors: B A Kakulas
Journal: Nature Date: 1966-06-11 Impact factor: 49.962

12 in total

1. The science of clinical neurology.

Authors: J Walton
Journal: J R Soc Med Date: 1986-01 Impact factor: 5.344

Review 2. Cellular autoimmunity to muscle: a review.

Authors: M Esiri
Journal: Proc R Soc Med Date: 1977-05

3. Lymphocyte sensitivity to human skeletal muscle antigen in polymyositis.

Authors: M M Esiri; B L Hazleman; I C MacLennan
Journal: Ann Rheum Dis Date: 1973-05 Impact factor: 19.103

4. Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders.

Authors: M M Esiri; I C MacLennan; B L Hazleman
Journal: Clin Exp Immunol Date: 1973-05 Impact factor: 4.330

5. Methotrexate therapy in polymyositis.

Authors: F C Arnett; J C Whelton; T M Zizic; M B Stevens
Journal: Ann Rheum Dis Date: 1973-11 Impact factor: 19.103

6. Immunological and ultrastructural observations on the role of lymphoid cells in the pathogenesis of polymyositis.

Authors: F L Mastaglia; S Currie
Journal: Acta Neuropathol Date: 1971 Impact factor: 17.088

Review 7. The inflammatory myopathies.

Authors: J Walton
Journal: J R Soc Med Date: 1983-12 Impact factor: 5.344